Protocol Ledger

NCT04547049 · Phase III · ACTIVE NOT RECRUITING

A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

Interventional Phase III clinical trial protocol NCT04547049 sponsored by First Affiliated Hospital of Zhejiang University in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-09-01 Enrollment: 232 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04547049
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)232 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04547049
Protocol FieldVerified Registry Value
NCT IdentifierNCT04547049
Consolidated Lead SponsorFirst Affiliated Hospital of Zhejiang University
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment232 participants (ESTIMATED)
Registered Start Date2020-09-01
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI